Bacterial Pneumonia Panel (Mycoplasma pneumoniae, S. pneumoniae & Chlamydia Genus), Molecular Detection
Test Code: 13356 | CPT Code: Use individual CPTCodes |
Specimen Type: Swab (throat swab/ nasopharyngeal swab)/ respiratory secretions/ BAL | |
Sample Volume: 1/2.0 mL/ 2.0 mL/ 1.0 mL | |
Transport Condition: Refrigerated condition/ room temperature | |
Specimen Rejection Criteria: Calcium alginate-tipped swab, wood swab, or transport swab containing gel | |
Methodology: PCR | |
Special Requirements: Specimen source is required. Clinical history needed. | |
Clinical Significance: This assay is used for rapid detection of DNA of common respiratory pathogens (Mycoplasma pneumoniae, S. pneumoniae & Chlamydia Genus) in the clinical specimens, which aids in the diagnosis of pneumonias caused by the same. |
|
Run Day: Mon, Wed, Fri | |
Reporting Day: 4th day |
Barbiturates, urine
Test Code: 1137 | CPT Code: 82205 |
Specimen Type: Urine random in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Flowchromatographic Immunoassay | |
Special Requirements: The test is only for screening purpose | |
Clinical Significance: Extensively used as hypnotics, sedatives and anesthetics. Readily absorbed from stomach. Duration of action of barbiturates in therapeutic doses varies from: 8-16 hrs (long acting, e.g., phenobarbital); 4-8 hrs (intermediate acting, e.g., amobarbital); 3-6 hrs (short acting, e.g., pentobarbital). Barbiturates may enhance other CNS depressants, such as ethanol, morphine derivatives, tranquilizers, and resperine. |
|
Run Day: Daily | |
Reporting Day: Next day |
Basal Metabolic Panel (BMP) Chem-7 (Glucose Random, Creatinine, Urea, Calcium Total, Bicarbonate, Sodium, Potassium, Chloride)
Test Code: 1301 | CPT Code: 80048 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay/ spectrophotometry/ISE | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays. |
|
Run Day: Daily | |
Reporting Day: 2nd day |
Basic Metabolic Panel (Calcium, Ionized) (Glucose Random, Creatinine, Urea, Calcium Ionized, Bicarbonate, Sodium, Potassium, Chloride)
Test Code: 3833 | CPT Code: 80047 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Immunoassay/ spectrophotometry/ISE | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays. |
|
Run Day: Daily | |
Reporting Day: 2nd day |
Basic Metabolic Panel (Calcium,Total) (Glucose Random, Creatinine, Urea, Calcium total, Bicarbonate, Sodium, Potassium, Chloride)
Test Code: 3834 | CPT Code: 80048 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay/ spectrophotometry/ISE | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays. |
|
Run Day: Daily | |
Reporting Day: 2nd day |
BCR/ ABL, Qualitative (Philadelphia Chromosome)
Test Code: 8414 | CPT Code: 81206,81207, 81208 |
Specimen Type: Whole blood in Paxgene tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: | |
Specimen Rejection Criteria: Sample received in any other tube. Received at room temperature. | |
Methodology: Real Time PCR | |
Special Requirements: Clinical details in specified format is required | |
Clinical Significance: BCR/ ABL qualitative assay is used in diagnostic workup of patients with high probability of BCR-ABL-positive hematopoietic neoplasms, predominantly chronic myelogenous leukemia and acute lymphoblastic leukemia. |
|
Run Day: Mon, Wed, Fri | |
Reporting Day: 4th day |
Bence Jones Protein, Urine
Test Code: 1268 | CPT Code: 86335 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 50 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: NA | |
Methodology: Immunoturbidimetry | |
Special Requirements: No special precautions needed | |
Clinical Significance: The presence of free light chains (i.e., Bence-Jones proteins) or light chain dimers in the urine are often characteristic of myelomatosis. A polyclonal increase in free light chains occurs in certain renal diseases associated with nephron loss (e.g., nephropathy associated with systemic lupus erythematosus) and is a resultof altered renal catabolism of immunoglobulins. |
|
Run Day: Daily | |
Reporting Day: Next day |
Benzodiazepine, Urine
Test Code: 1138 | CPT Code: 80154 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 20 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Flowchromatographic Immunoassay | |
Special Requirements: The test is only for screening purpose | |
Clinical Significance: Drug of abuse |
|
Run Day: Daily | |
Reporting Day: Same day |
Beta 2 Glycoprotein Antibodies, IgG, Serum
Test Code: 6898 | CPT Code: 86146 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Beta-2-glycoprotein , apolipoprotein H, is a cofactor in antiphospholipid antibodies binding and is the critical antigen in the antiphospholipid antibodies syndrome. Beta-2-glycoprotein antibodies is more specific than cardiolipin antibodies; cardiolipin may express reactivity in patients with syphilis and other infectious diseases. |
|
Run Day: Wed | |
Reporting Day: Next day |
Beta 2 Glycoprotein Antibodies, IgM, Serum
Test Code: 6899 | CPT Code: 86146 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Beta-2-glycoprotein , apolipoprotein H, is a cofactor in antiphospholipid antibodies binding and is the critical antigen in the antiphospholipid antibodies syndrome. Beta-2-glycoprotein antibodies is more specific than cardiolipin antibodies; cardiolipin may express reactivity in patients with syphilis and other infectious diseases. |
|
Run Day: Wed | |
Reporting Day: Next day |
Beta 2 Transferin, Fluid
Test Code: 13109 | CPT Code: 86335 |
Specimen Type: Serum + nasal fluid (collected same day) | |
Sample Volume: 2 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Nil | |
Methodology: Electrophoresis | |
Special Requirements: Clinical history is required | |
Clinical Significance: The diagnosis of cerebrospinal fluid (CSF) rhinorrhea or otorrhea (leakage of CSF into the nose or ear, usually as a result of head trauma, tumor, congenital malformation, or surgery) is often difficult to confirm.Traditional chemical assays (glucose, protein, specific gravity etc) are unreliable. Radiographic studies are costly and may entail additional risks to the patient. |
|
Run Day: Daily | |
Reporting Day: 5th day |
Beta Carotene, Serum
Test Code: 7475 | CPT Code: 82380 |
Specimen Type: Serum (red-top tube), protected from light | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Specimen other than serum. Received room temperature. Received not protected from light. Hemolyzed or icteric specimens | |
Methodology: Spectrophotometry | |
Special Requirements: Overnight fasting is required. Separate serum as soon as possible after clotting. Wrap tube in aluminum foil to protect from light. Clinical details are required. | |
Clinical Significance: Beta Carotene is a fat soluble nutrient, and is a precursor of vitamin A. Deficiency of this compound can lead to vitamin A deficiency. Excessive vitamin A intake may lead to headaches, |
|
Run Day: Mon | |
Reporting Day: 4th day |
Beta HCG, Titre
Test Code: 2890 | CPT Code: 84702 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: No special precautions needed | |
Clinical Significance: This assay is used for diagnosing pregnancy and aids in the investigation of suspected ectopic pregnancy. It is also used for monitoring In vitro fertilization patients. It is also used to detect the cases of choriocarcinoma. |
|
Run Day: Daily | |
Reporting Day: Same day |
Beta Thalassemia Mutation Detection (ARMS PCR)
Test Code: 7430 | CPT Code: No CPTcode |
Specimen Type: Whole blood in lavender-top (EDTA) tube | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: PCR | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Molecular genetic testing of HBB, the gene encoding the hemoglobin subunit beta, may be useful for predicting the clinical phenotype in some cases as well as pre-symptomatic diagnosis |
|
Run Day: Tue | |
Reporting Day: 7th day |
Beta Thalassemia Profile (CBC, PBS, Reticulocyte Count, Hb Variant Analysis, Ferritin)
Test Code: 6248 | CPT Code: Use individual CPTCodes |
Specimen Type: Whole blood in EDTA tube & serum collected in a yellow-top tube | |
Sample Volume: Whole blood - 5.0 mL, serum -2.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Grosshemolysis/clot (EDTA) | |
Methodology: HPLC, Spectrophotometry, electrophoresis | |
Special Requirements: Clinical history is essential | |
Clinical Significance: This panel is useful in the diagnosis of beta thalassemia. It quantitates the percent of fetal hemoglobin and assists in the diagnosis of disorders with elevated levels of HbF. |
|
Run Day: Daily | |
Reporting Day: Same day |
Beta-CrossLaps (CTx-1) Osteoporosis Monitoring
Test Code: 15968 | CPT Code: 82523 |
Specimen Type: Serum (red/ yellow-top tube) | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Frozen | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: Twelve hours before this blood test, do not take multivitamins or dietary supplements containing biotin or vitamin B7. Fasting sample required. | |
Clinical Significance: Beta-CTx is released into the bloodstream during bone resorption and serves as a specific marker for the degradation of mature type I collagen. This assay aids monitoring antiresorptive therapies (eg, bisphosphonates and hormone replacement therapy) in postmenopausal women treated for osteoporosis and individuals diagnosed with osteopenia, and is also used as an adjunct in the diagnosis of medical conditions associated with increased bone turnover. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Bicarbonates, Serum
Test Code: 278 | CPT Code: 82374 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: vHemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Measurement are used in the diagnosis and treatment of numerous potentially serious disorders associated with changes in body acid-base balance. |
|
Run Day: Daily | |
Reporting Day: Same day |
Bile acids, Total, Serum
Test Code: 6869 | CPT Code: 82239 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grosshemolysis, gross icterus | |
Methodology: Spectrophotometry | |
Special Requirements: Fasting, 8-hour minimum. Do not order in patients receiving bile acid therapy. | |
Clinical Significance: This test is used as an aid in the evaluation of liver function, evaluation of liver function changes before the development of more advanced clinical signs such as icterus, an aid in the evaluation of hepatic dysfunction because of chemical/ environmental injuries, an indicator of hepatic histological improvement in chronic hepatitis C patients on interferon therapy, and an indicator for intrahepatic cholestasis of pregnancy. |
|
Run Day: Wed | |
Reporting Day: Same day |
Bilirubin, Direct, Serum
Test Code: 4865 | CPT Code: 82248 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis and anticoagulants other than heparin | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: The assessment of direct bilirubin is helpful in the differentiation of hepatic disorders. The increase in total bilirubin associated with obstructive jaundice is primarily due to the direct (conjugated) fraction. Both direct and indirect bilirubin are increased in the serum with hepatitis. |
|
Run Day: Daily | |
Reporting Day: Same day |
Bilirubin, Neonatal, POCT
Test Code: 5784 | CPT Code: 82247 |
Specimen Type: Heparinized venous whole blood in a green- top (heparin) tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: POCT | |
Special Requirements: No special precautions needed | |
Clinical Significance: Same as bilirubin important for preventing kernicterus |
|
Run Day: Daily | |
Reporting Day: Same day |
Bilirubin, Total & Direct, Serum
Test Code: 1183 | CPT Code: 82247,82248 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis and anticoagulants other than heparin | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: The assessment of direct bilirubin is helpful in the differentiation of hepatic disorders. The increase in total bilirubin associated with obstructive jaundice is primarily due to the direct (conjugated) fraction. Both direct and indirect bilirubin are increased in the serum with hepatitis. In the newborn patient with hemolytic jaundice and neonatal jaundice, the increase in the total bilirubin is primarily due to the indirect (unconjugated) bilirubin fraction. |
|
Run Day: Daily | |
Reporting Day: Same day |
Bilirubin, Total, Serum
Test Code: 4864 | CPT Code: 82247 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis and anticoagulants other than heparin | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Levels of bilirubin are used in the diagnosis and treatment of liver, hemolytic, hematologic and metabolic disorders, including hepatitis and gallbladder obstructive disease. |
|
Run Day: Daily | |
Reporting Day: Same day |
Biopsy & Immunofluorescent Assay, {Histopath + IgG + IgA + IgM + C3 + C1q + Fibrinogen on Tissue (with Photograph)}
Test Code: 13175 | CPT Code: 88346,88305 |
Specimen Type: | |
Sample Volume: | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: If both specimen are received in formalin, or if both are received without formaline. Specimen without specified transport media | |
Methodology: Microscopy, Immunofluorescence | |
Special Requirements: Clinical history is required | |
Clinical Significance: Immunofluorescence is a histochemical staining technique used for demonstration of antibodies bound to antigens in the tissue/ circulating body fluids. This assay is essential for diagnosis, treatment and follow up of conditions like skin immunobullous disorders (Eg. pemphigus and pemphigoid groups, dermatitis herpetiformis, lupus erythematosus & other collagen vascular diseases), various types of glomerulonephritis, and renal humoral anti-graft reaction. |
|
Run Day: Daily | |
Reporting Day: 5th day |
Bladder, Cystectomy
Test Code: 1416 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Bleeding Time (BT)
Test Code: 439 | CPT Code: 85002 |
Specimen Type: Conducted on patient | |
Sample Volume: Done on patient | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Ivy method | |
Special Requirements: Only walking patients | |
Clinical Significance: Screening for bleeding tendency. |
|
Run Day: Daily | |
Reporting Day: Same day |
Blood Cell Morphology (PBF)
Test Code: 441 | CPT Code: 85060 |
Specimen Type: Whole blood in a lavender-top (EDTA) tube | |
Sample Volume: 3 mL | |
Transport Condition: Refrigerated condition. | |
Specimen Rejection Criteria: Clotted sample | |
Methodology: Microscopy | |
Special Requirements: No special precautions needed | |
Clinical Significance: To assist in diagnosis of hematological disorders. |
|
Run Day: Daily | |
Reporting Day: Same day |
Blood typing; ABO
Test Code: 4888 | CPT Code: 86900 |
Specimen Type: Whole blood EDTA (lavender-top tube) | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Hemolysis and lipemia | |
Methodology: Column Agglutination | |
Special Requirements: No special precautions needed | |
Clinical Significance: Determination of blood group; essential for blood transfusion |
|
Run Day: Daily | |
Reporting Day: Same day |
Blood typing; Rh (D)
Test Code: 4889 | CPT Code: 86901 |
Specimen Type: Whole blood EDTA (lavender-top tube) | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Hemolysis and lipemia | |
Methodology: Column Agglutination | |
Special Requirements: No special precautions needed | |
Clinical Significance: Determination of blood group; essential for blood transfusion |
|
Run Day: Daily | |
Reporting Day: Same day |
BNP (Natriuretic Peptide), Serum
Test Code: 1309 | CPT Code: 83880 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: BNP is increased in congestive heart failure, left ventricular hypertrophy, acute myocardial infarction, coronary angioplasty, and hypertension. Elevations are also observed in pulmonary hypertension (indicating right ventricular dysfunction), acute lung injury, hypervolemic states, chronic renal failure and cirrhosis. |
|
Run Day: Daily | |
Reporting Day: Next day |
BoBs (BACs on Beads) for Prenatal samples Karyolyte kit (covers all 24 chromosmes)
Test Code: 13190 | CPT Code: No CPTcode |
Specimen Type: Peripheral blood in heparin tube (green top), products of con- ception, tissue biopsy, amniotic fluid & chorionic villi biopsy | |
Sample Volume: Blood 3-5 mL, fluid 10 - 15 mL & tissue 5 to 10 gms | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Tissues transported other than media | |
Methodology: Suspension array-based multiplex assay | |
Special Requirements: Use only sterile transport media, supplied by Thumbay Labs for sample transportation. | |
Clinical Significance: The test will assist in detecting of common chromosome abnormalities that includes known deletions, duplications and numerical abnormalities |
|
Run Day: Sun | |
Reporting Day: 4th working day from the run day |
BoBs (BACs on Beads) Single Cell Analysis from IVF samples Karyolyte kit (covers all 24 chromosmes)
Test Code: 13188 | CPT Code: No CPTcode |
Specimen Type: Single cell from IVF (In vitro fertilization) sample | |
Sample Volume: Single cell | |
Transport Condition: Frozen below -20 degree C | |
Specimen Rejection Criteria: Cell received in non frozen condition | |
Methodology: Suspension array-based multiplex assay | |
Special Requirements: Biopsied blastomeres should be maintained in drops of Ca++ Mg++ free biopsy medium, before transferring them into sterile PCR tubes. | |
Clinical Significance: The test will assist in detecting of common chromosome abnormalities that includes known deletions, duplications and numerical abnormalities |
|
Run Day: Sun | |
Reporting Day: 4th working day from the run day |
BoBs (BACs on Beads) Prenatal BoBs kit (upto14 chromosomes)
Test Code: 13191 | CPT Code: No CPTcode |
Specimen Type: Peripheral blood in heparin tube (green top), products of con- ception, tissue biopsy, amniotic fluid & chorionic villi biopsy | |
Sample Volume: Blood 3-5 mL, fluid 10 - 15 mL & tissue 5 to 10 gms | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Tissues transported other than media | |
Methodology: Suspension array-based multiplex assay | |
Special Requirements: Use only sterile transport media, supplied by Thumbay Labs for sample transportation. | |
Clinical Significance: The test will assist in detecting of common chromosome abnormalities that includes known deletions, duplications and numerical abnormalities |
|
Run Day: Sun | |
Reporting Day: 4th working day from the run day |
BoBs(BACs on Beads) for Single Cell from IVF samples Prenatal kit (upto14 chromosomes)
Test Code: 13189 | CPT Code: No CPTcode |
Specimen Type: Single cell from IVF (In vitro Fertilization) sample | |
Sample Volume: Single cell | |
Transport Condition: Frozen below -20 degree C | |
Specimen Rejection Criteria: Cell received in non frozen condition | |
Methodology: Suspension array-based multiplex assay | |
Special Requirements: Biopsied blastomeres should be maintained in drops of Ca++ Mg++ free biopsy medium, before transferring them into sterile PCR tubes. | |
Clinical Significance: The test will assist in detecting of common chromosome abnormalities that includes known deletions, duplications and numerical abnormalities |
|
Run Day: Sun | |
Reporting Day: 4th working day from the run day |
Body Fluid Bronchial Brush, Washings, Lavage (Conventional Smears)
Test Code: 1452 | CPT Code: 88104 |
Specimen Type: Bronchial brush, washings, lavage | |
Sample Volume: 5 mL | |
Transport Condition: Body fluid preserved at 4 to 8 degree C | |
Specimen Rejection Criteria: Nil | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional smear is intended for use in screening for the presence of atypical cells, malignancies or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
Body fluid CSF (Conventional Smears)
Test Code: 1453 | CPT Code: 88112 |
Specimen Type: CSF | |
Sample Volume: 2 mL | |
Transport Condition: Body fluid preserved at 4 to 8 degree C | |
Specimen Rejection Criteria: Nil | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional smear is intended for use in screening for the presence of atypical cells, malignancies or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
Body Fluid Pleural Fluid (Conventional Smears)
Test Code: 1454 | CPT Code: 88112 |
Specimen Type: Pleural fluid | |
Sample Volume: 5 mL | |
Transport Condition: Body fluid preserved at 4 to 8 degree C | |
Specimen Rejection Criteria: Nil | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional smear is intended for use in screening for the presence of atypical cells, malignancies or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
Body Fluid Routine Analysis
Test Code: 1167 | CPT Code: 89050 |
Specimen Type: Any body fluids | |
Sample Volume: 5.0 mL | |
Transport Condition: Body fluid preserved at 4 to 8 degree C | |
Specimen Rejection Criteria: Grossly hemorrhagic fluid | |
Methodology: Conventional smears | |
Special Requirements: No special precautions needed | |
Clinical Significance: On identification of the organism, antibiotic susceptibilities are performed that aid in selection of appropriate antibiotic for treatment. |
|
Run Day: Daily | |
Reporting Day: Same day |
Body Fluid Sputum (Conventional Smears)
Test Code: 1455 | CPT Code: 88112 |
Specimen Type: Sputum | |
Sample Volume: 0.5 mL | |
Transport Condition: 4 to 8 degree C | |
Specimen Rejection Criteria: Saliva only | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional smear is intended for use in screening for the presence of atypical cells, malignancies or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
Body Fluid Stomach Lavage (Conventional Smears)
Test Code: 1456 | CPT Code: 88160 |
Specimen Type: Stomach lavage | |
Sample Volume: 5 mL | |
Transport Condition: Body fluid preserved at 4 to 8 degree C | |
Specimen Rejection Criteria: Nil | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional smear is intended for use in screening for the presence of atypical cells, malignancies or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
Body Fluid Synovial Fluid (Conventional Smears)
Test Code: 1457 | CPT Code: 88160 |
Specimen Type: Synovial fluid | |
Sample Volume: 2 mL | |
Transport Condition: Body fluid preserved at 4 to 8 degree C | |
Specimen Rejection Criteria: Nil | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional smear is intended for use in screening for the presence of atypical cells, malignancies or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
Bone Biopsy (Single Block)
Test Code: 1348 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Bone Bone Curetting
Test Code: 1373 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 5th day |
Bone Femoral Head Excision
Test Code: 1374 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 5th day |
Bone Marrow (Terphine Biopsy) Needle Biopsy
Test Code: 1350 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Bone Marrow Aspirate
Test Code: 1349 | CPT Code: 88305 |
Specimen Type: Bone marrow | |
Sample Volume: Smear fixed immediately with spray fixative or 95% ethyl alcohol | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Slide broken in transit beyond ability to repair | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/ confirmed through bone marrow smear examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Bone Metabolic Profile (Vitamin D Total, Calcium, Alkaline Phosphatase, Creatinine)
Test Code: 6251 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis, gross lipemia | |
Methodology: Immunoturbidimetry, Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays |
|
Run Day: Daily | |
Reporting Day: Same day |
Bone Resection for Tumor
Test Code: 1417 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 5th day |
Borrelia (Lyme disease) Antibodies, IgG & IgM, Serum
Test Code: 337 | CPT Code: 86617 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Grosshemolysis and hyperlipemia | |
Methodology: Enzyme immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Western blot testing is appropriate for confirming a positive (detected) EIA or IFA test result. IgG western blot strips which have 5 (or more) of the 10 significant bands are considered positive for specific antibodies to |
|
Run Day: Thurs | |
Reporting Day: Next day |
Breast Nipple Discharge Cytology (Conventional Smears)
Test Code: 266 | CPT Code: 88160 |
Specimen Type: Breast Nipple Discharge | |
Sample Volume: Smear fixed immediately with spray fixative or 95% ethyl alcohol | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Slide broken in transit beyond ability to repair | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: For detection of malignant cells. |
|
Run Day: Daily, Except Fri | |
Reporting Day: Next day |
Breast, Core Needle Biopsy/ Incisional Biopsy
Test Code: 1351 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Breast, Lumpectomy
Test Code: 1375 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Breast, Lumpectomy (Large)
Test Code: 1392 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Breast, Mammographically directed excision
Test Code: 1418 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Breast, Mastectomy
Test Code: 1419 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Bronchial Brush Examination, Washings and Lavage
Test Code: 1442 | CPT Code: 88104 |
Specimen Type: Bronchial wash | |
Sample Volume: 5 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Inadequate quantity | |
Methodology: Microscopy | |
Special Requirements: Sample to be collected as as inpatient procedure and sent to the lab for examination | |
Clinical Significance: The nature of possible underlying disease states can often be ruled out/confirmed through examination of body fluid |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Brucella Antibodies, IgG, Quantitative, Serum
Test Code: 6851 | CPT Code: 86622 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received at room temperature, EDTA lavender-top, hemolysis and lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Brucellosis is caused by transmission from animal to human. Brucella abortus is transmitted from cattle. A high titer of IgM suggest recent exposure. A lower titre of IgG may indicate past exposure or treated infection |
|
Run Day: Thurs | |
Reporting Day: Next day |
Brucella Antibodies, IgM, Quantitative, Serum
Test Code: 6874 | CPT Code: 86622 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received at room temperature, EDTA lavender-top, hemolysis and lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Brucellosis is caused by transmission from animal to human. Brucella abortus is transmitted from cattle. A high titer of IgM suggest recent exposure. A lower titre of IgG may indicate past exposure or treated infection |
|
Run Day: Thurs | |
Reporting Day: Next day |
Brucella Antibodies, IgM, Serum
Test Code: 15949 | CPT Code: 86622 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic | |
Methodology: Enzyme immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Worldwide, brucellosis remains a major disease in humans and domesticated animals. This assay aids in evaluating patients with suspected brucellosis. |
|
Run Day: Thurs | |
Reporting Day: Same day |
Brucella Antibodies, Serum
Test Code: 338 | CPT Code: 86622 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received at room temperature, EDTA lavender-top, hemolysis and lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Brucellosis is caused by transmission from animal to human. Brucella abortus is transmitted from cattle. A high titer of IgM suggest recent exposure. A lower titre of IgG may indicate past exposure or treated infection |
|
Run Day: Daily | |
Reporting Day: Next day |